Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives

  title={Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives},
  author={Jonathan P. Rogers and Cameron J. Watson and James Badenoch and Benjamin Cross and Matthew Butler and Jia Song and Danish Hafeez and Hamilton Morrin and Emma Rachel Rengasamy and Lucretia Thomas and Silviya Ralovska and Abigail Smakowski and Ritika Dilip Sundaram and Camille Kaitlyn Hunt and Mao Fong Lim and Daruj Aniwattanapong and Vanshika Singh and Zain U. Hussain and Stuti Chakraborty and Ella Burchill and Katrin Jansen and Heinz Holling and Dean Walton and Thomas A. Pollak and Mark Ellul and Ivan Koychev and Tom Solomon and Benedict Daniel Michael and Timothy R. Nicholson and Alasdair G Rooney},
  journal={Journal of Neurology, Neurosurgery, and Psychiatry},
  pages={932 - 941}
  • J. Rogers, C. Watson, A. Rooney
  • Published 26 February 2021
  • Psychology, Medicine
  • Journal of Neurology, Neurosurgery, and Psychiatry
There is accumulating evidence of the neurological and neuropsychiatric features of infection with SARS-CoV-2. In this systematic review and meta-analysis, we aimed to describe the characteristics of the early literature and estimate point prevalences for neurological and neuropsychiatric manifestations. We searched MEDLINE, Embase, PsycINFO and CINAHL up to 18 July 2020 for randomised controlled trials, cohort studies, case-control studies, cross-sectional studies and case series. Studies… 

Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis

Neuropsychiatric symptoms are common and persistent after recovery from COVID-19, but indicates a particularly high frequency of insomnia, fatigue, cognitive impairment, and anxiety disorders in the first six months after infection.

Pregnancy and neurologic complications of COVID‐19: A scoping review

The case reports of pregnant women with confirmed SARS‐CoV‐2 infection plus a specified neurologic diagnosis plus a specific diagnosis of COVID‐19, including one patient who also had vestibular neuritis, Bell's palsy, and rhabdomyolysis are summarized.

Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection

Neurocognitive and psychiatric post-COVID-19 long-term conditions are frequent and complex multifactorial sequelae that include microglial activation and astrogliosis.

Extrapulmonary clinical manifestations of COVID-19: an umbrella review of meta-analysis

A summary of recent meta-analyses is presented by categorizing the various extra-pulmonary clinical symptoms of COVID-19 according to organ systems to provide clinicians concise information and promote the understanding of administrators who set appropriate quarantine policies.

Neurocognitive Screening in Patients Following SARS-CoV-2 Infection: Tools for Triage

Cognitive performance is associated with neuropsychiatric symptoms in ambulatory but not hospitalized patients, and focal cognitive deficits are more common in hospitalized than ambulatory patients.

Increased ethnicity and socioeconomic data collection required in stroke associated with COVID-19

The letter by Dmytriw et al, which highlighted potential racial disparities in outcomes from ischaemic stroke after COVID-19, highlighted the need to elucidate mechanisms that may drive an interaction between stroke and CO VID-19 to explain increased mortality in ethnic minorities.

Global Publications on Covid-19 and Neurosciences: A Bibliometric Assessment during 2020-21

A bibliometric assessment of global literature of the peripheral and central neurological manifestations of Covid-19 and Neurosciences, which will help to improve decision-making among physicians treating Covids and also aid on the pandemic management of the disease.

Delirium and COVID‐19: a narrative review of emerging evidence

The pandemic has played out on the national stage and the effect of delirium on patients, relatives and healthcare workers remains unknown but evidence from the previous SARS outbreak suggests there may be long‐lasting psychological damage.



Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions

Identifying some neurological manifestations like smell and taste disturbances can be used to screen patients with COVID-19 so that early identification and isolation is possible.

Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis

Lab, electrophysiological, radiological, and pathological evidence supported neurologic involvement of COVID-19, suggesting neurological involvement is an important aspect of the disease.

Neurologic Characteristics in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis

Doctors should be aware of the presence of neurologic signs and symptoms as a chief complaint of COVID-19, in order to improve management and prevent a worsening outcome of the patients, according to the Oxford Center for Evidence-Based Medicine guidelines.

Prevalence of Headache in Patients With Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of 14,275 Patients

From the first 4-month data of the outbreak, headache was detected in 10.1% of the adult COVID-19 patients, with no significant difference of headache prevalence in severe or critical vs. non-severe patients.

A prospective clinical study of detailed neurological manifestations in patients with COVID-19

Headache was the most common seen neurological symptom in this disease and it is suggested that determining these neurological symptoms prevents the diagnosis delay and helps to prohibit virus spread.

Early neurological manifestations of hospitalized COVID-19 patients

Headache in association with arthralgia and muscle pain seems to reflect the common symptoms of the flu-like syndrome, and not COVID-19 infection-specific, as well as the possible relationship between plasmatic inflammatory indices and olfactory disorders (ODs), muscle pain and creatine kinase (CK).

Neurological associations of COVID-19